HPV

Focus magnify target strategy
Biotech

Nykode bets future on cancer trial after losing Genentech pact

While the axing of the Genentech deal was the initial blow, Nykode is also contending with the potential loss of future revenues from Regeneron.
Nick Paul Taylor Aug 27, 2025 8:25am
next step ladder climb succeed win

PDS reports 39 months OS in phase 2 head and neck cancer trial

Aug 25, 2025 9:00am
A map of Texas and surrounding states

BD to study HPV self-collection in underserved Texas communities

Nov 21, 2024 10:45am
HPV

GSK drops ph. 2 HPV vaccine over lack of best-in-class potential

Jul 31, 2024 8:06am
OB GYN office gynecologist

FDA approves self-collection screening for HPV, cervical cancer

May 15, 2024 11:03am
arrow miss target fail attempt try

Barinthus HPV drug doesn't prove efficacy

Apr 19, 2024 9:50am